Aethlon Medical (AEMD) Liabilities and Shareholders Equity (2011 - 2025)

Aethlon Medical (AEMD) has 15 years of Liabilities and Shareholders Equity data on file, last reported at $8.1 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 23.47% year-over-year to $8.1 million; the trailing twelve-month figure through Dec 2025 stood at $28.0 million (down 19.95% YoY), and the FY2025 full-year result was $7.4 million, down 10.75% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $8.1 million, up from $7.3 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $25.9 million in Q2 2021 and bottomed at $5.3 million in Q2 2025.
• The 5-year median for Liabilities and Shareholders Equity is $12.1 million (2023), against an average of $14.1 million.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity jumped 82.0%; it then sank 53.52% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $21.9 million in 2021, then decreased by 5.44% to $20.7 million in 2022, then sank by 49.64% to $10.4 million in 2023, then plunged by 37.48% to $6.5 million in 2024, then rose by 23.47% to $8.1 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $8.1 million (Q4 2025), $7.3 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.

Peer Comparison